Home > Boards > US OTC > Biotechs > Cytodyn Inc. (CYDY)

Thanks for posting, Emergcy! Maybe this is the

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
B52T38 Member Profile
Member Level 
Followed By 13
Posts 571
Boards Moderated 0
Alias Born 09/09/17
160x600 placeholder
Quarterly Report (10-q) Edgar (US Regulatory) - 1/10/2022 5:13:42 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/5/2022 5:16:52 PM
CytoDyn's leronlimab in 350 mg weekly dose met endpoints in Phase 2 NASH trial Seeking Alpha - 1/5/2022 9:38:39 AM
IQST - $0.60 Sleeper Stock Set To Explode In Fintech Parade Of Decacorn IPO's InvestorsHub NewsWire - 12/23/2021 11:51:16 AM
CytoDyn receives positive response from FDA for Phase 3 leronlimab study in COVID-19 Seeking Alpha - 12/21/2021 9:28:46 AM
CytoDyn files for expanded access use of leronlimab for HIV patients Seeking Alpha - 12/9/2021 9:13:36 AM
Amended Statement of Changes in Beneficial Ownership (4/a) Edgar (US Regulatory) - 11/30/2021 6:32:42 PM
Amended Statement of Changes in Beneficial Ownership (4/a) Edgar (US Regulatory) - 11/30/2021 6:32:41 PM
Amended Statement of Changes in Beneficial Ownership (4/a) Edgar (US Regulatory) - 11/30/2021 6:31:47 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/29/2021 6:30:28 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/29/2021 6:27:57 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/29/2021 6:20:40 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/24/2021 5:22:56 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/24/2021 4:05:01 PM
CytoDyn reports leronlimab data in NASH trial for first 15 patients Seeking Alpha - 11/24/2021 10:08:44 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/23/2021 5:24:15 PM
SA Breaking News - PURA estimates $1M in 2022 revenue InvestorsHub NewsWire - 11/22/2021 9:38:18 AM
PURA BULLISH RESURGANCE InvestorsHub NewsWire - 11/19/2021 8:50:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/17/2021 6:02:41 AM
CytoDyn submits the first section of HIV BLA to FDA under rolling review Seeking Alpha - 11/16/2021 7:07:29 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/9/2021 4:55:20 PM
CytoDyn submits leronlimab Breakthrough Therapy designation application to the FDA Seeking Alpha - 11/8/2021 7:50:43 AM
Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a) Edgar (US Regulatory) - 11/5/2021 11:30:49 AM
CytoDyn posts preliminary results from mid-stage leronlimab NASH study Seeking Alpha - 11/3/2021 6:11:13 AM
iQSTEL, Inc. - The Calm Before The Surge (OTCQX: IQST) InvestorsHub NewsWire - 10/29/2021 2:31:48 PM
B52T38 Member Level  Thursday, 11/25/21 10:37:06 AM
Re: Emergcy post# 194716
Post # of 201276 
Thanks for posting, Emergcy! Maybe this is the first peer-reviewed, publicized shot across the bow of mandatory vaccinations. If an employer demands to know on what rational basis an employee has to question the mandate (besides being unconstitutional), this would be an excellent reference to cite.

May God Bless you and your family today, and everyone else who is grateful to wake up in the greatest, most blessed nation on Earth. Happy Thanksgiving!

And thank you, Squanto, wherever you are.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences